Donor management, organ preservation, organ distribution coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: Patterns and contributing factors

Journal of Heart and Lung Transplantation

Volumn 18, Issue 3, 1999, Pages 239-247

  Kevelaitis, Egidijus ^a   Nyborg, Niels C Berg ^b   Menasché, Philippe ^c  

^a Medical University   (Lithuania)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CARDIOPLEGIC AGENT; ISOPRENALINE; PAPAVERINE; PHENYLEPHRINE; PLEGISOL; PRESERVATION SOLUTION; PROSTAGLANDIN F2 ALPHA; SEROTONIN; SODIUM CHLORIDE; ST THOMAS HOSPITAL SOLUTION; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CRYOPRESERVATION; CULTURE MEDIUM; ENDOTHELIUM LESION; GRAFT REJECTION; HEART PERFUSION; HEART PRESERVATION; HEART TRANSPLANTATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR DISEASE; ANIMAL; COLD; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; ORGAN PRESERVATION; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TIME; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; COLD; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART TRANSPLANTATION; ISOPROTERENOL; MALE; MUSCLE, SMOOTH, VASCULAR; ORGAN PRESERVATION; PHENYLEPHRINE; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SEROTONIN; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0033091009     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00042-4     Document Type: Article

References (35)

1. Hosenpud J.D., Novick R.J., Bennett L.E., et al. The Registry of the International Society for Heart and Lung Transplantation thirteenth official report-1996 . J Heart Lung Transp. 15:1996;655-674.
2. Day J.D., Rayburn B.K., Gaudin P.B., et al. Cardiac allograft vasculopathy the central pathogenic role of ischemia-induced endothelial cell injury . J Heart Lung Transplant. 14:1995;S142-S149.
3. Gao S.Z., Alderman E.L., Schroeder J.S., Silverman J.F., Hunt S.A. Accelerated coronary vascular diseases in the heart transplant patient coronary arteriography findings . J Am Coll Cardiol. 12:1988;334-340.
4. Heroux A.L., Silverman P., Costanzo M.R., et al. Intracoronary ultrasound of morphological and functional abnormalities associated with cardiac allograft vasculopathy. Circulation. 89:1994;272-277.
5. Amrani M., Chester A.H., Jayakumar J., Schyns C.J., Yacoub M.H. L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res. 30:1995;200-204.
6. Briganti E.M., Bergin P.J., Rosenfeld F.L., Esmore D.S., Rabinov M. Successful long-term outcome with prolonged ischemic time cardiac allografts. J Heart Lung Transplant. 14:1995;840-845.
7. Obadia J.F., Girard C., Ferrara R., Chuzel M., Chassignolle J.F., Dureau G. Long conservation organs in heart transplantation Postoperative results and long-term follow-up in fourteen patients . J Heart Lung Transplant. 16:1997;256-269.
8. Wheeldon D., Sharples L., Wallwork J., English T. Donor heart preservation survey. J Heart Lung Transplant. 11:1992;986-993.
9. Menasché P., Termignon J.L., Pradier F., et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur Cardio-thorac Surg. 8:1994;207-213.
10. Nyborg N.C.B. Action of noradrenaline on isolated proximal and distal coronary arteries of rat Selective release of endothelium-derived relaxing factor in proximal arteries . Br J Pharmacol. 100:1990;552-556.
11. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 41:1977;19-26.
12. Nyborg N.C.B., Baandrup U., Mikkelsen E.O., Mulvany M.J. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries. Pflügers Arch. 410:1987;664-670.
13. Nyborg N.C.B., Mikkelsen E.O. 5-Hydroxytryptamine does not release endothelium-derived relaxing factor in rat isolated coronary arteries. Eur J Pharmacol. 186:1990;295-300.
14. Katayama O., Amrani M., Ledingham S., et al. Effect of cardioplegia infusion pressure on coronary artery endothelium and cardiac mechanical function. Eur J Cardio-thorac Surg. 11:1997;751-762.
15. Hearse D.J., Stewart D.A., Braimbridge M.V. Cellular protection during myocardial ischemia the development and characterization of a procedure for the induction of reversible ischemic arrest . Circulation. 54:1976;193-202.
16. Amrani M., Mankad P.S., Yacoub M.H. Improved preservation of endothelial function at 4°C. Eur J Cardio-thorac Surg. 6:1992;72-78.
17. Quillen J.E., Sellke F.W., Brooks L.A., Harrison D.G. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 82:1990;586-594.
18. Pietri S., Culcasi M., Albat B., Albérici G., Menasché P. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study. Transplantation. 58:1994;739-742.
19. Menasché P., Pradier F., Peynet J., Grousset C., Bloch G., Piwnica A. Limitation of free radical injury by reduced glutathione an effective means of improving the recovery of heart transplants . Transplant Proc. 23:1991;2440-2442.
20. Kevelaitis E., Nyborg N.C.B., Menasché P. Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage. Transplantation. 64:1997;660-663.
21. 2+ by liver mitochondria. J Biol Chem. 259:1984;1279-1287.
22. Kukreja R.C., Hess M.L. The oxygen free radical system from equation through membrane-protein interactions to cardiovascular injury and protection . Cardiovasc Res. 26:1992;641-655.
23. Gryglewski R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature. 320:1986;454-456.
24. Rubanyi G.M., Vanhoutte P.M. Superoxide anion and hypoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 250:1986;H822-H827.
25. Bernard M., Menasché P., Canioni P., et al. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. J Thorac Cardiovasc Surg. 90:1985;235-242.
26. +-ATPase. J Mol Cell Cardiol. 24:1992;465-470.
27. 2+-ATPase of cardiac sarcoplasmic reticulum. Circ Res. 69:1991;1003-1014.
28. Jennings R.B., Reimer K.A., Steenbergen C. Myocardial ischemia revisited the osmolar load, membrane damage and reperfusion . J Mol Cell Cardiol. 18:1986;769-780.
29. Belzer F.O., Southard J.H. Principles of solid-organ preservation by cold storage. Transplantation. 45:1988;673-676.
30. Menasché P., Hricak B., Pradier F., et al. Efficacy of lactobionate-enriched cardioplegic solution in preserving of cold-stored heart transplants. J Heart Lung Transplant. 12:1993;1053-1061.
31. Von Oppel U.O., Pfeiffer S., Preiss P., Dunne T., Zilla P., Reichart B. Endothelial cell toxicity of solid-organ preservation solutions. Ann Thorac Surg. 50:1990;902-910.
32. Kevelaitis E., Mouas C., Menasché P. Poststorage diastolic abnormalities of heart transplants Is vascular dysfunction or myocardial contracture the culprit? J Heart Lung Transplant. 15:1996;461-469.
33. Drexler H., Fishell T.A., Pinto F.J., et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation. 89:1994;1615-1623.
34. Boyle E.M., Pohlman T.H., Cornejo C.J., Verrier E.D. Endothelial cell injury in cardiovascular surgery ischemia-reperfusion . Ann Thorac Surg. 62:1996;1868-1875.
35. Perrault L.P., Bidouard J.-P., Janiak P., et al. Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. J Heart Lung Transplant. 16:1997;643-657.